Tag: Business News

  • NHI Implementation: Understanding the Reform Facts

    Recent scepticism regarding National Health Insurance (NHI) has sparked intense debate across the business sector. With NHI Implementation underway, much of this criticism relies on overhyped concerns rather than policy realities. The healthcare industry needs to ground these discussions in fact and context. NHI is not a sudden shift. It is the result of over a decade of policy development…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Discovery’s Interim Results Highlight Strong Growth

    Discovery has announced a significant surge in its financial performance for the first half of the year. The group expects headline earnings to rise by nearly a third. Discovery’s interim results follow a period of robust operational success across its various divisions. The South African-based financial services giant released a trading statement covering the six months ending 31 December. The…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Life Healthcare Share Price Stumbles Following R2.9bn Liability Adjustment

    The Life Healthcare share price took a significant knock in early trade yesterday, falling by as much as 9%. This happened after the hospital group released a trading statement detailing a multi-billion Rand adjustment to its financial liabilities. Investors reacted sharply to news that an R2.9bn adjustment related to the “Piramal liability” had heavily impacted profit from continuing operations. This…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Ascendis Health Exits JSE and Positions for Growth

    Ascendis Health has confirmed its plan to delist from the JSE in the first week of December, following an overwhelming mandate from its investors. This decision marks the culmination of the company’s significant turnaround strategy. Not long ago, it faced the prospect of bankruptcy. A resounding 93% of the company’s shareholders voted in favour of the move. This provides CEO…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Aspen Unlocking Value with New Manufacturing Strategies

    Aspen Pharmacare’s CEO, Stephen Saad, has declared that all hands are on deck to overhaul the group’s manufacturing business. He identified the performance of its sterile unit as a significant drag on earnings. This underperformance has caused the market to undervalue the company. This move is part of Aspen’s effort to unlock value for its stakeholders and enhance its market…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Mediclinic AI Strategy Targets R2 Billion Savings Amid Job Freezes

    Mediclinic announced major operational changes. The hospital group aims to achieve R2 billion in annual savings. Mediclinic set this goal for the 2027 financial year. A pivot to Artificial Intelligence drives this shift. This forms the core of the new Mediclinic AI strategy. Mediclinic is transforming its corporate landscape. It has frozen new non-essential hires. Mediclinic now offers voluntary severance…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • SA Pharma Sector Unfazed by US Tariffs Impact

    The SA pharma sector remains unfazed. South Africa’s largest trade association for pharmaceutical manufacturers has stated that it foresees no immediate risk to the local sector. This follows the announcement of sweeping tariffs by US President Donald Trump last week. According to Stavros Nicolaou, Chair of the Pharmaceutical Task Group (PTG), several factors mitigate the impact on the nation’s drug…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in